Key Takeaways
- • Private equity dominance in supplements M&A: L Catterton, the world's largest consumer-focused PE firm with ~$37 billion in AUM, leads acquisitive activity in the vitamins, minerals, and supplements (VMS) sector, with recent high-profile deals including Thorne (valued at ~$680 million in 2023, now seeking $4 billion valuation) and RAW Nutrition (acquired by CVC Partners' Quality Group platform in April 2025).
- • Strategic pharma and consumer goods acquisitions accelerate: Sanofi acquired Qunol, a leading U.S. CoQ10 supplement brand; Nestlé completed acquisition of The Bountiful Company's core brands; and Kingswood Capital Management and Performance Investment Partners acquired The Vitamin Shoppe in May 2025, signaling sustained consolidation among tier-one acquirers.
- • Recurring revenue model drives investor appeal: The supplements and active nutrition category remains a high-priority investment thesis for PE globally, driven by strong consumer demand, predictable revenue streams, and defensive characteristics—positioning the sector as a defensive alternative investment within consumer goods.
- • Broader portfolio consolidation extends beyond core supplements: Major acquirers are pursuing adjacent consumer health categories, including feminine care brands (Carefree, Stayfree, o.b.) acquired across U.S., Canada, and Caribbean markets, demonstrating platform-building and cross-category revenue expansion strategies.
Summary
The global vitamins, minerals, and supplements (VMS) market is undergoing significant consolidation driven by both private equity firms and strategic corporate buyers seeking exposure to defensive consumer health categories with recurring revenue characteristics. L Catterton, managing approximately $37 billion in equity capital and positioned as the world's largest consumer-focused private equity firm, has emerged as the dominant institutional acquirer in the space, establishing a platform approach to roll-up fragmented supplement brands and maximize operational synergies.
Recent transaction activity reflects sustained acquisition momentum across multiple segments. Sanofi, the France-based pharmaceutical and consumer healthcare company, acquired Qunol, a well-established U.S. supplement brand specializing in CoQ10 products, representing strategic expansion into the nutritional supplements category by a major pharmaceutical player. Nestlé, the world's largest food company, completed its acquisition of The Bountiful Company's core brands through Nestlé Health Science, while also pursuing adjacent consumer categories including feminine care brands (Carefree, Stayfree, and o.b.) across North American and Caribbean markets. More recent deals include Kingswood Capital Management and Performance Investment Partners' acquisition of The Vitamin Shoppe completed in May 2025, and CVC Partners' Quality Group platform acquisition of RAW Nutrition in April 2025.
L Catterton's portfolio activity underscores the institutional capital focus on the sector. The firm's 2023 take-private acquisition of Thorne at approximately $680 million has already generated significant value creation, with the company now seeking valuations as high as $4 billion—illustrating the margin expansion potential and strategic value these brands command. Beyond L Catterton, other consumer-focused PE platforms including WM Partners and category-specific nutritional wellness investors have established acquisition programs targeting branded, consumer-facing supplement businesses.
The investment thesis driving consolidation centers on three core factors: sustained consumer demand for preventive health and wellness products, predictable recurring revenue models from subscription and repeat purchase channels, and operational consolidation opportunities in a highly fragmented market. Private equity acquirers are explicitly excluding pet supplements and contract manufacturers from primary acquisition targets, focusing instead on branded, direct-to-consumer supplement businesses with established market positions and customer loyalty. This disciplined approach reflects investor sophistication in targeting assets with pricing power and customer lifetime value expansion potential rather than commoditized manufacturing operations.
Recent transaction activity reflects sustained acquisition momentum across multiple segments. Sanofi, the France-based pharmaceutical and consumer healthcare company, acquired Qunol, a well-established U.S. supplement brand specializing in CoQ10 products, representing strategic expansion into the nutritional supplements category by a major pharmaceutical player. Nestlé, the world's largest food company, completed its acquisition of The Bountiful Company's core brands through Nestlé Health Science, while also pursuing adjacent consumer categories including feminine care brands (Carefree, Stayfree, and o.b.) across North American and Caribbean markets. More recent deals include Kingswood Capital Management and Performance Investment Partners' acquisition of The Vitamin Shoppe completed in May 2025, and CVC Partners' Quality Group platform acquisition of RAW Nutrition in April 2025.
L Catterton's portfolio activity underscores the institutional capital focus on the sector. The firm's 2023 take-private acquisition of Thorne at approximately $680 million has already generated significant value creation, with the company now seeking valuations as high as $4 billion—illustrating the margin expansion potential and strategic value these brands command. Beyond L Catterton, other consumer-focused PE platforms including WM Partners and category-specific nutritional wellness investors have established acquisition programs targeting branded, consumer-facing supplement businesses.
The investment thesis driving consolidation centers on three core factors: sustained consumer demand for preventive health and wellness products, predictable recurring revenue models from subscription and repeat purchase channels, and operational consolidation opportunities in a highly fragmented market. Private equity acquirers are explicitly excluding pet supplements and contract manufacturers from primary acquisition targets, focusing instead on branded, direct-to-consumer supplement businesses with established market positions and customer loyalty. This disciplined approach reflects investor sophistication in targeting assets with pricing power and customer lifetime value expansion potential rather than commoditized manufacturing operations.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.